Y-mabs therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Y-mabs therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 24.359 million compared to usd 11.415 million a year ago. net loss was usd 23.922 million compared to usd 11.426 million a year ago. basic loss per share was usd 0.7 compared to usd 0.42 a year ago. for the nine months, operating loss was usd 59.246 million compared to usd 29.152 million a year ago. net loss was usd 57.892 million compared to usd 29.214 million a year ago. basic loss per share was usd 1.69 compared to usd 1.08 a year ago.
YMAB Ratings Summary
YMAB Quant Ranking